NCT01757587View on ClinicalTrials.gov

Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

Vildagliptin

50 mg, 2 tablets/day on 3 months, both periods of treatment

DRUG

Placebo

50mg 2 tablets / day on 3 months, both periods of treatment

Trial Locations (1)

91000

CH Sud Francilien, Évry

All Listed Sponsors
lead

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

NCT01757587 - Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin | Biotech Hunter | Biotech Hunter